Individuals highlight — January 2022


Ajinomoto Bio-Pharma Providers, a contract improvement and manufacturing group (CDMO), introduced that Tony O’Neill has joined the group as vp of compliance, US operations. O’Neill brings intensive expertise main high quality, manufacturing, and operational excellence groups within the pharma and biopharma sectors. He joins Aji Bio-Pharma after 25 years at Allergan, a pharma agency the place he held plenty of high quality and operational management positions in biologics manufacturing and improvement, with duty each in Eire and US operations.

AGC Biologics, a CDMO, unveiled that Regina Choi-Rivera would be the new basic supervisor of the corporate’s large-scale biopharma mammalian manufacturing facility in Boulder, CO. On this function, she assumes government oversight and management, and can handle strategic improvement and facility operations.

Abzena, a companion analysis group (PRO) for biopharma outsourced options, from idea to clinic and into good manufacturing apply (GMP) manufacturing, has introduced the appointment of Jim Kennamer as senior vp and website head of North Carolina. With over 30 years’ expertise within the pharma business, Kennamer has held numerous positions with rising ranges of obligations at Boehringer Mannheim Biochemical, Roche Molecular Biochemicals, Diosynth, Strategene and Talecris Biotherapeutics/Grifols Therapeutics. He has deep expertise with manufacturing operations and processes, notably in course of enhancements.

Pharma heavyweight Merck introduced that Frank Clyburn, government vp and president, human well being, will depart the corporate on Feb. 1, 2022, to imagine a management alternative with one other firm. Management of human well being following Frank’s departure will probably be revealed within the coming weeks. Clyburn joined Merck in 2008 and held a number of management positions with rising duty all through his Merck profession.

CAI, a worldwide consulting firm that gives technical, operational consulting, and mission administration companies to life sciences, information facilities, and industrial course of manufacturing industries, reported that Michael Martin, CAI president, has succeeded Bob Chew as CEO, efficient as of Jan. 1, 2022. Chew is continuous as chairman of the board and chief innovation officer.

The Worldwide Air Transport Affiliation (IATA) has appointed Frederic Leger because the affiliation’s senior vp for industrial services. Leger served within the function on an advert interim foundation since July 2021, when IATA’s industrial services division was created as a part of an inside restructuring. He experiences to Willie Walsh, IATA’s director basic.

The Sanner Group, a worldwide provider of packaging options and parts for the medtech, diagnostics, pharma and healthcare industries, has appointed Adrian Possumato as president of Sanner of America, Inc. He’ll assist the Sanner Group, with its shareholders GHO Capital and Sanner Ventures, in accelerating worldwide development plans, primarily by creating capabilities to facilitate the US market growth.

Emergent BioSolutions Inc. introduced that Fuad El-Hibri, founder and government chairman, has determined to retire, efficient April 1, 2022. The life sciences firm anticipates that El-Hibri will nonetheless be obtainable as wanted to successfully transition his data to the board of administrators and administration group. Emergent expects to call a brand new chair of the board of administrators forward of El-Hibri’s retirement.

Syneos Well being,, a biopharma scientific and industrial options group, has appointed two new unbiased administrators, Barbara W. Bodem and Alfonso G. Zulueta, to its board of administrators. Bodem will function a Class I director and can serve on the corporate’s audit committee, whereas Zulueta will function a Class III director. Bodem served because the senior vp and CFO at Hillrom, a worldwide medical know-how firm, from 2018 till its acquisition by Baxter Worldwide Inc. in 2021, and presently serves on the board of administrators of Turning Level Therapeutics, Inc., a clinical-stage precision oncology firm. Zulueta has over three many years of expertise in international strategic and management roles inside giant pharma, particularly with Eli Lilly and Firm.



Supply hyperlink